United States · Platforms & data · MarketBeat

Ultragenyx Pharmaceutical Inc. (RARE) - What Are Investment Firms Saying About This Stock?

Published by MarketBeat · United States 43 min ago

Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Get Free Report) has received an average recommendation of "Hold" from the twenty-two research firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eleven have assigned a ho

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

U.S., allies agree to coordinate AI supply chain security

MarketWatch

Nvidia is gearing up for one of Wall Street’s most anticipated earnings calls in years

Investing.com

Mexico’s Guadalajara cartel founder, aged 80, dies in hospital, Milenio reports

CNBC

Lutnick faces questions over Nvidia spy scandal. His sons' firm has ties to the chipmaker

Yahoo Finance

Plumbing Detectives LLC Publishes a First-Hour Plumbing Checklist for Seasonal Residents Returning to Venice, Florida Homes

TipRanks